Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.35M Sell
6,163
-3
-0% -$484 0.65% 27
2025
Q1
$862K Buy
6,166
+115
+2% +$18.7K 0.46% 36
2024
Q4
$1.01M Buy
6,051
+1,965
+48% +$349K 0.53% 32
2024
Q3
$696K Sell
4,086
-224
-5% -$32.4K 0.57% 34
2024
Q2
$609K Hold
4,310
0.54% 33
2024
Q1
$541K Hold
4,310
0.5% 35
2023
Q4
$454K Buy
+4,310
New +$470K 0.44% 41

Other funds holding ORCL

Breed's Hill Capital's ORCL Position: Q2 2025 in Review

Breed's Hill Capital reduced its Oracle (ORCL) stake by 0.05% in Q2 2025, selling an estimated $484 and leaving 6,163 shares worth $1.35M. The position accounts for 0.65% of the portfolio, ranked #27.

Breed's Hill Capital first reported a position in ORCL in Q4 2023 and has held it in 7 quarters since. 3,627 funds tracked by Wall St. Rank hold ORCL as of Q2 2025.

  • Breed's Hill Capital held 6,163 shares of Oracle worth $1.35M as of Q2 2025.
  • Breed's Hill Capital sold 3 Oracle shares in Q2 2025, an estimated $484.
  • Oracle made up 0.65% of Breed's Hill Capital's portfolio in Q2 2025, its #27 holding.
  • Breed's Hill Capital first reported a position in Oracle in Q4 2023 and has held it in 7 quarters since.
  • 3,627 funds tracked by Wall St. Rank held Oracle as of Q2 2025.

Based on Breed's Hill Capital's 13F filing for Q2 2025, filed 8 Aug 2025.